Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.

Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

CAP TODAY Webinars

Accelerating Precision Medicine with Rapid Front-Line NGS-April 30, 2026

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC, discusses how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Multicenter Evaluation of Next-Day CGP Using the Oncomine™ Comprehensive Assay Plus on the Genexus™ System-April 28, 2026

Webinar presenters Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Morten Grauslund, PhD,Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark, discuss how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Automated and integrated genomic profiling of hematologic malignancies-March 5, 2026

Join Dr. David Gonzalez, one of the leading experts in the EuroClonality-NGS working group of the Euroclonality consortium, dedicated to advancing standardized diagnostics in hematology-oncology, to learn:

  • How EuroClonality-NDC and Myeloid-NDC NGS Workflows are utilized in advancing
    the future of diagnostics, prognostics, and targeted therapies.
  • How these revolutionary assays provide comprehensive genomic data that reveals
    mutations, structural variations, and clonal evolution patterns with remarkable resolution, enabling clinical researchers to delve deeper into the genomic landscape of hematological malignancies.

From Cough to Critical: The Role of Syndromic Respiratory Testing Across the Care Continuum-January 21, 2026


Webinar presenters Shyam M. Sivasankar, MD, FAAP, FACEP, Associate Trauma Medical Director & Assistant Professor, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, and Dan Feinstein, MD, FACP, Director of Pulmonary Critical Care Medicine, Triad Region; System-wide Director, TeleICU & Co-Director, Sepsis, Novant Health, team up for this session bringing together two physicians—one representing inpatient and critical care from a large health system, and the other offering a perspective on urgent and near-patient care—to share how syndromic polymerase chain reaction (PCR) testing informs real-world patient management.

Unlocking Fertility Insights: The Power of AMH in Reproductive Health-September 24, 2025


Webinar presenters Wendy Vitek, MD, Board-certified Reproductive Endocrinologist, Boston IVF’s Syracuse, NY Fertility Center, and Shirley Li, MD, PhD, Associate Professor-Clinical, Department of Pathology; Director of Clinical Pathology Services and Co-Director of the Clinical Chemistry & Toxicology Laboratory, The Ohio State University, explore Anti-Müllerian Hormone (AMH) from both analytical and clinical perspectives.

Pathologist Perspectives: Experience Leveraging the Genius® Digital Diagnostics System for Digital Cytology-October 29, 2025


Webinar presenters Liron Pantanowitz, MD, PhD, MHA, Chair and Maud Menten Professor of Pathology, UPMC/University of Pittsburgh UPMC Shadyside Hospital, and Richard Lozano, MD, President, P&C Labs, LLC. and Vice President, Chipps, Caffrey, Dubilier, and PSC, discuss their experience with the Genius Digital Diagnostics System and data leveraging digital cytology for cervical cancer screening.

Introduction of a new FDA approved rapid NGS solution for Companion Diagnostics and tumor profiling in oncology-August 27, 2025


Webinar presenters David Chi, PhD, Director of Oncology Product Management, Thermo Fisher Scientific, and Gary Pestano, PhD, Chief Development Officer, Biodesix, Inc., and Bence Sipos, MD, Molecular Pathology, Baden-Württemberg, Stuttgart, Germany, discusses the rapidly evolving field of precision oncology, the increasing availability of targeted treatments offers renewed hope to patients.

REGISTER NOW

Automated and integrated genomic profiling of hematologic malignancies

Thursday, March 5, 2026
11:00 AM–12:00 PM ET

Learn how EuroClonality-NDC and Myeloid-NDC NGS Workflows are utilized in advancing the future of diagnostics, prognostics, and targeted therapies and how these revolutionary assays provide comprehensive genomic data that reveals mutations, structural variations, and clonal evolution patterns with remarkable resolution, enabling clinical researchers to delve deeper into the genomic landscape of hematological malignancies.

Webinar presenters David Gonzalez, PhD, FRCPath, CEO, Univ8 Genomics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.

Register Now.

MARKETPLACE

TRENDING